Carbapenemase-producing gram-negative bacteria (CP-GNB) are an urgent and expanding public health threat. Rapid and accurate identification of these organisms facilitates infection prevention efforts in healthcare facilities. The objective of our study was to evaluate methods to detect and identify CP-GNB.
The rapid emergence and expansion of carbapenemresistant gram-negative bacteria (CR-GNB) 2 is an urgent global public health threat (1, 2 ) . Carbapenemases, or enzymes that can degrade broad-spectrum ␤-lactams including carbapenems, can be located on mobile genetic elements, facilitating the spread of resistance genes between organisms. Although numerous carbapenemase genes have been described to date, the most common determinants conferring carbapenem resistance in the US include bla KPC (Ambler class A), bla NDM (Ambler class B), and bla OXA-48-like (Ambler class D) (3) (4) (5) . These enzymes are most frequently isolated from Enterobacteriaceae, including Klebsiella pneumoniae, Enterobacter spp., and Escherichia coli. Additionally, they have been identified in other GNB, including Pseudomonas aeruginosa and Acinetobacter spp. (3, 6, 7 ) . Accurate detection and characterization of carbapenemase-producing GNB (CP-GNB) can inform infection-prevention measures, be important for epidemiological purposes, and help expedite appropriate therapy in infected patients. For example, ceftazidime-avibactam has activity against Ambler classes A and C ␤-lactamases, but not Ambler classes B and D (8 -10 ) .
Methods in the clinical microbiology laboratory for the detection of CP-GNB rely on phenotypic detection of carbapenem resistance in concert with molecular studies to identify and characterize the genetic determinants conferring carbapenem resistance. Historically, the modified Hodge test (mHT) was recommended as a first-line method to detect carbapenemase production in Enterobacteriaceae (11 ) . However, this method has important limitations, both with regard to analytical sensitivity and specificity. For example, false-negative results are commonly reported for metallo-␤-lactamases, such as bla NDM , and false-positive results are reported in isolates with compound antimicrobial resistance phenotypes, such as AmpC and/or extended-spectrum ␤-lactamase (ESBL) enzymes with a porin mutation (12 ) . In addition, a positive mHT does not inform the genetic determinant conferring carbapenem resistance. Our objective in this investigation was to evaluate 3 emerging methods to detect carbapenem resistance in GNB--the carbapenem inactivation method (CIM), Cepheid Xpert Carba-R, and chromogenic agar.
Materials and Methods

BACTERIAL ISOLATES
One hundred and twenty bacterial strains (98 Enterobacteriaceae, 15 P. aeruginosa, and 7 Acinetobacter baumannii complex) were obtained from archived clinical isolates at Barnes-Jewish Hospital (St. Louis, MO). These isolates were originally recovered between 2011 and 2016 from different specimen types, including urine, blood, respiratory specimens, body fluids, tissues, and wounds. All isolates previously tested as not susceptible (i.e., intermediate or resistant) to meropenem using Kirby-Bauer disk diffusion (disk diffusion zone of Յ22 mm) (12 ) . For the purpose of evaluation herein, all nonsusceptible isolates are described here as "resistant." Additional isolates from the Enterobacteriaceae Carbapenemase Diversity Panel were obtained from the CDC Antimicrobial Resistance Isolate Bank (Atlanta, GA) (13 ) . An additional 18 clinical isolates from our laboratory's strain bank were evaluated. An overview of all isolates and carbapenemase genes evaluated is found in Table 1 . For all tests, the following organisms were used for quality control: K. pneumoniae ATCC BAA-1705 (bla KPC positive strain), K. pneumoniae ATCC 700603 (ESBL-positive, carbapenemasenegative strain), and E. coli ATCC 29522 (carbapenemsusceptible strain).
BACTERIAL CULTIVATION
From frozen stock, each isolate was inoculated onto blood agar plates (Hardy Diagnostics). A 10-g meropenem disk (Becton, Dickinson and Company) was placed in the first quadrant to confirm retention of meropenem resistance upon storage and subculture. Isolates were suspended in normal saline to a density of 0.5 McFarland (McF) standard (14 ) for workup; the same suspension was used for each of the assays evaluated.
CARBAPENEM INACTIVATION METHOD
Using a method modified from van der Zwaluw et al.
(15 ), a heaping 10-L loop of each isolate was suspended in 400 L tryptic soy broth (TSB) in a 1.5 mL Eppendorf tube. Growth nearest to the meropenem disk on the subculture plate was selected for analysis. The suspension was vortex-mixed for 10 s and a 10 g meropenem disk was added to each tube and vortex-mixed again for 10 -30 s. Tubes were incubated at 35°C in air for 3-4 h. After incubation, each disk was placed onto a MuellerHinton agar plate inoculated with a 0.5 McF standard of E. coli ATCC 29522 (a meropenem-susceptible strain). Up to 8 disks were placed onto each 150-mm plate. As a control, a meropenem disk incubated in TSB without any organism was also tested each time testing was performed. Plates were incubated at 35°C in air and the zone around the meropenem disk was measured and recorded at 6 h and again after an overnight incubation (18 -24 h). A positive result for a carbapenemaseproducing isolate was indicated by uninhibited growth of the E. coli (evaluated using a zone size Յ8 mm). A negative result for carbapenemase production resulted when a large zone of inhibition of E. coli was observed around the meropenem disk (zone size Ն15 mm). Based on preliminary testing, a meropenem zone size of 9 -14 mm was classified as indeterminate (data not shown). For isolates requiring additional testing to query for production of a metallo-␤-lactamase, 50 L of 0.5 mol/L EDTA was added to the TSB with a meropenem disk and the test organism and incubated as described above (CIM-EDTA). A positive result (suggestive of a metallo-␤-lactamase) was a zone size difference of Ն5 mm around the meropenem disk for the isolate incubated with EDTA as compared to without EDTA. The instructions for this procedure are included in the Supplemental Methods file that accompanies the online version of this article at http://www.clinchem.org/content/vol63/issue3.
CIM TO mHT COMPARISON STUDY
To compare the performance characteristics of the CIM method to the mHT, a subset of 20 organisms representing a variety of resistance determinants (6 bla KPC , 3 bla NDM , 3 bla VIM , 3 bla OXA-48-like , 1 bla IMP , and 4 carbapenemase-negative, meropenem-resistant isolates) were tested using both the CIM and mHT. The mHT was set up per the protocol in the CLSI M100-26S document (12 ) . Ten experienced microbiologists interpreted both assays.
EVALUATION OF GROWTH ON CHROMOGENIC AGAR
HardyCHROM CRE Agar (Hardy Diagnostics) and chromID CARBA Agar (bioMérieux) were evaluated. Using a Pasteur pipette, 2 drops of a 0.5 McF standard of each isolate were placed onto each plate and streaked using a 4-quadrant method for isolation. Each plate was incubated at 35°C in air and protected from the light.
Plates were examined at 24 and 48 h and relevant growth characteristics, including colony color and a semiquantitative assessment of growth (i.e., 1ϩ to 4ϩ), were recorded for each strain.
CEPHEID Xpert Carba-R ASSAY
The Xpert Carba-R assay detects and differentiates 5 carbapenemase genes (bla KPC , bla NDM , bla IMP , bla OXA-48-like , and bla VIM ). According to manufacturer's directions, a 10-L loopful of the 0.5 McF standard suspension of each organism was added to a 5 mL vial of Xpert Carba-R Sample Reagent and vortex-mixed for 10 s (16 ) . Using the provided transfer pipette, the sample reagent was added to the Xpert Carba-R cartridge and analyzed using the Cepheid GeneXpert platform (Cepheid) . 
STATISTICAL ANALYSES
For each assay evaluated, positive percent agreement (PPA) and negative percent agreement (NPA) were calculated using an aggregate gold standard as follows. For a positive result, the isolate must be meropenem intermediate or resistant and be positive for a carbapenemase gene using the laboratory-developed PCR assays or must have been previously characterized as part of the CDC Carbapenemase Diversity Panel as possessing a carbapenemase. For a negative result, meropenem susceptibility or negativity for a carbapenemase gene must be confirmed by the laboratory-developed PCR assays or per the CDC Carbapenemase Diversity Panel (21 ) .
Results
CARBAPENEM INACTIVATION METHOD
Of the 189 meropenem-resistant GNB evaluated, all isolates possessing a carbapenemase gene (bla KPC , bla NDM , bla OXA-48-like , bla IMP , bla VIM , bla SME , or bla IMI ) by PCR or by the CDC reference panel were positive by the CIM (zone around meropenem disk of Յ8 mm), with the exception of 1 isolate of Proteus mirabilis possessing the bla NDM gene, which was indeterminate due to the swarming characteristics of this species. Zone sizes for the Enterobacteriaceae isolates could easily be interpreted af-ter a 6-h incubation period and were sustained following overnight incubation. P. aeruginosa isolates that contained the bla VIM gene (n ϭ 4) were difficult to interpret after the 6-h incubation, with zones of 12-16 mm, but after the overnight incubation all zones measured 6 -8 mm. One Providencia rettgeri isolate and 5 A. baumannii complex isolates, all of which tested negative by both the Xpert Carba-R assay and the real-time PCRs for bla KPC , bla NDM , and bla OXA-48-like , were positive by the CIM. Isolates that were negative by PCR, but positive by the CIM, were evaluated using the CIM-EDTA, which tests for the presence of a metallo-␤-lactamase (Fig. 1) . The carbapenemase produced by the P. rettgeri isolate and 5 of 6 of the A. baumannii complex isolates were inactivated with the addition of EDTA. The addition of EDTA to the TSB with the meropenem disk inhibited carbapenemase activity, leading to a larger zone around the disk (18 mm with EDTA vs 6 mm without EDTA for the P. rettgeri; 15-18 mm with EDTA vs 6 -7 mm without EDTA for the A. baumannii complex). Accurate performance of the CIM-EDTA was confirmed using bla NDM and bla VIM (metallo-␤-lactamases) positive isolates.
Overall, the CIM demonstrated 99.3% PPA and 86.0% NPA for carbapenemase production with the aggregate reference standard (Table 2) . A comparison of interpretations of the CIM vs the mHT is shown in Table 3 . Although the mHT is described by CLSI for Enterobacteriaceae and not for nonfermenting GNB, isolates of P. aeruginosa (n ϭ 3) and Acinetobacter spp. (n ϭ 1) were included in this analysis for consistency in testing and to capture all of the resistance mechanisms included in this study. For the mHT, P. aeruginosa isolates possessing a bla VIM (n ϭ 3) were difficult to interpret due to the presence of a zone of lighter "haze" of growth up to the meropenem disk. A correct interpretation was provided for all isolates with a bla KPC , bla OXA-48-like , and bla IMP gene. In contrast, 8 of 10 readers interpreted the bla NDM -positive isolates as negative, while the other readers interpreted the isolate as positive (n ϭ 1) and indeterminate (n ϭ 1). For CRGNBs that were negative for a carbapenemase, all 4 isolates were interpreted as negative by the CIM, while some readers interpreted these isolates as positive or indeterminate using the mHT (Table 3) . Overall, there was agreement between technologists for 16/20 isolates for the CIM and 11/20 isolates for the mHT. For the CIM with this subset of isolates, the PPA and NPA were 97.5% and 100%, respectively, while for the mHT the PPA was 75% and the NPA was 58.5%. For the purpose of these calculations, indeterminate results were considered positive, since carbapenemase production would not be ruled out and these isolates would require additional characterization/workup. The CIM facilitated ease of correct interpretations as expected for all Enterobacteriaceae.
EVALUATION OF THE Xpert Carba-R ASSAY
We evaluated the analytical performance characteristics of the Xpert Carba-R assay for the detection of bla KPC , bla NDM , bla OXA-48-like , bla IMP , and bla VIM genes. The Xpert Carba-R assay has a hands-on time of approximately 1-2 min per sample with an analysis time of less than 1 h (16 ). Positive results were obtained for all isolates previously characterized as possessing the carbapen- Growth immediately around the meropenem disk represents the test organism with which the disk was incubated. emase genes detected by the assay. Fifty isolates of CR-GNB that were negative for a carbapenemase gene (Table  1) also tested negative by the Xpert Carba-R assay. As expected, isolates that possessed other carbapenemases included in the CDC panel but not in the Xpert Carba-R assay (bla SME and bla IMI ) tested negative by the Xpert Carba-R assay. Thus, the PPA and NPA for detection of bla KPC , bla NDM , bla OXA-48-like , bla IMP , and bla VIM in bacterial isolates using the Xpert Carba-R are both 100%. The PPA and NPA for detection of any carbapenemase gene are 94.2% and 100.0%, respectively (Table 2).
CHROMOGENIC AGARS
Two chromogenic agars were evaluated in this study: HardyCHROM CRE and chromID CARBA agars. The agars were evaluated for recovery of meropenem-resistant organisms, and for specificity for recovery of CP-GNB. Both the Enterobacteriaceae and other GNB grew well on both agars (see online Supplemental Table 1 ). Overall, there was little difference between observations made at 24 h vs 48 h of incubation, with similarity between relative growth and color of the isolates at the different time points. Of the 2 P. mirabilis isolates included in this study, one (bla KPC positive) did not grow on either agar and the other (bla NDM positive) grew poorly (first quadrant only) on the HardyCHROM CRE but grew well on the chromID CARBA agar. The HardyCHROM CRE agar had more intraspecies color variation compared to the chromID CARBA agar (see online Supplemental Fig.  1 ). The colors produced by the organisms were as described in the product monograph for most isolates, although some variation did occur (see online Supplemental Fig. 2 ).
With the exception of 1 bla KPC -positive Proteus mirabilis isolate that did not grow on either media type, all CP-GNB isolates grew on both agars. One bla OXA-48-likepositive Enterobacter aerogenes grew only on the first quadrant on the chromID CARBA agar. For CR-GNB isolates that were negative for a carbapenemase gene, a The numbers represent the number of individual technologists scoring the reaction for the isolate as positive, negative, or indeterminate. n = 20 results per isolate, 10 for CIM and 10 for mHT. b For the mHT, technologists marked "indeterminate" if they were not able to confidently score the isolate as positive or negative.
53/58 isolates grew on the HardyCHROM CRE agar. The 5 CR-GNB isolates that either did not grow or grew poorly (first or second quadrant only) included 1 Enterobacter cloacae, 1 Klebsiella pneumoniae, and 3 Serratia marcescens. The chromID CARBA agar was more specific for growth of CP-GNB isolates. Twenty isolates of CR-GNB (3 E. aerogenes, 10 E. cloacae, 2 K. pneumoniae, 1 Escherichia coli, 1 Hafnia alvei, 1 Klebsiella oxytoca, 1 Pseudomonas aeruginosa, and 1 Providencia rettgeri) either failed to grow or grew poorly on the agar.
Discussion
Resistance to carbapenem antibiotics is considered an international public health threat. Throughout the world there are increasing cases of clinical infections with CP-GNB, including Enterobacteriaceae, P. aeruginosa, and A. baumannii complex. Herein, we have evaluated different methods for the screening and detection of CP-GNB. We examined 189 isolates previously characterized as meropenem-resistant, including 138 known carbapenemase-producing strains.
The CIM used herein is an adaptation of the method of van der Zwaluw et al. (15 ) . The adaptation improves the analytical performance characteristics of the assay, and also provides the ability to identify metallo-␤-lactamase-producing strains. This method is a simple, inexpensive, and relatively rapid screen for CP-GNB that could be performed in any clinical microbiology laboratory. The modifications to the method of Zwaluw et al. include the use of TSB instead of water for the incubation step of the test bacteria isolate with the meropenem disk, and extension of the incubation time to 3-4 h as compared to the 2-h incubation time previously described. These modifications have the potential to increase the analytical sensitivity of the assay for isolates with weak carbapenemase activity.
The CIM uses materials commonly found in clinical laboratories (microcentrifuge tubes, meropenem disks, TSB, and Mueller-Hinton agar). Additionally, as demonstrated in the CIM to mHT comparison, this assay is less ambiguous to interpret compared to the mHT. For most Enterobacteriaceae, testing can be completed within 9 h with very little hands-on time (approximately 5 min). We used an overnight incubation for P. aeruginosa and A. baumannii complex since they were difficult to interpret at 6 h of incubation. Our comparison study between the CIM and mHT demonstrated that the CIM method is not only analytically more sensitive and specific than the mHT, but also has less interreader variability. The analytical specificity was especially improved for isolates of Enterobacter spp. since these isolates were likely AmpC hyperproducing strains, which have been previously described to cause false-positive results with the mHT (22, 23 ) .
Although the CIM demonstrated high overall percent agreement with the reference methods, 1 strain of P. mirabilis with a bla NDM carbapenemase gave an ambiguous result because the zone around the meropenem disk was unable to be measured as a result of swarming of the P. mirabilis isolate. For nonfermenters, the growth of the carbapenem-susceptible E. coli surrounding the meropenem disks that were incubated with carbapenemase (bla VIM ) producing P. aeruginosa was not as robust as for the Enterobacteriaceae and required full overnight incubation for interpretation. As bla VIM was the only carbapenemase gene in our collection of P. aeruginosa isolates, it is not clear if this growth characteristic would be present with other CR genes in P. aeruginosa or if it is a product of the bla VIM determinant in this species. The 3 bla VIMpositive Enterobacteriaceae isolates (2 K. pneumoniae and 1 E. cloacae) evaluated were unambiguous to interpret.
It is possible that the 7 "false-positives" by the CIM assay are actually CP-GNB strains possessing carbapenemase genes not detected by the PCR assays included in this study. Interestingly, we demonstrated that the P. rettgeri isolate and 5 of the 6 A. baumannii complex isolates tested were positive by CIM but negative by PCR. Using our CIM-EDTA assay, we confirmed that these isolates most likely encoded metallo-␤-lactamases. These isolates were considered negative for the purposes of calculating the NPA; however, it is possible that these strains harbor uncommon or novel carbapenemase genes.
This study is among the first to evaluate the enhanced Xpert Carba-R assay for detection of carbapenemase genes in bacterial isolates; the US Food and Drug Administration recently cleared this assay (24 -29 ) . The Xpert Carba-R assay demonstrated 100% PPA and NPA for the genetic targets represented in the assay. Prior evaluations of this method, albeit using an older version of the assay, demonstrated a decreased analytical sensitivity for the detection of bla OXA-48-like -positive (especially OXA-181) isolates (30 -33 ) . Since the discovery of bla OXA-48 , several variants have been identified that differ by only a few amino acid substitutions. bla OXA-181 , which is one of the most common variants, differs only by 4 amino acids from bla OXA-48 (34 ) . Our study included 12 bla OXA-48-like -positive isolates (11 K. pneumoniae and 1 E. aerogenes): 4 isolates were bla OXA-181 , 2 were bla OXA-232 , and 1 was a bla . Due to the previously reported false negatives for isolates with bla OXA-48-like genes, the assay was modified to increase sensitivity for detection of bla OXA-48 variants. Consequently, our data and other recent studies evaluating modifications of the assay demonstrated increased sensitivity for bla OXA-48-like -positive isolates (24, 28, 35, 36 ) .
In addition to testing for carbapenemase production, we also evaluated 2 chromogenic agars for their potential use in screening GNB isolates for carbapenemase production. The NPA for the detection of CP-GNB was higher for the chromID CARBA agar (25.0%) as compared to the HardyCHROM CRE agar (0.0%) ( Table 2 ). Both agars had growth of CR-GNBs, although the chromID CARBA agar had fewer breakthroughs of non-CP-GNB organisms (see online Supplemental Table 4 ). The superior performance of the chromID CARBA agar as compared to the HardyCHROM CRE agar to specifically recover CP-GNB was also demonstrated in a previous study (20 ) . As with the Xpert Carba-R assay, the detection of bla OXA-48-like -positive isolates has been reported to be poor using previous formulations of chromogenic agars (37) (38) (39) . In our study, all 12 of the bla OXA-48-like -positive isolates grew on both agars (third and fourth quadrants), although the E. aerogenes isolate only had growth in the first quadrant on the chromID CARBA agar.
Major strengths of this study include the large and diverse collection of isolates tested and the multiple methods of characterization performed, including a rapid and facile phenotypic method for carbapenemase detection from isolates of GNB. This study is limited by the evaluation of assay performance using only meropenemresistant GNB; therefore, we had a high pretest probability for the detection of isolates possessing carbapenemase. Additionally, only 1 bla IMP -positive isolate was evaluated in our study as a result of the scarcity of isolates with this genotype. At the time of writing, only 10 bla IMP -positive isolates have been reported in the US (40 ) .
Overall, the CIM followed by the Cepheid Xpert Carba-R assay is an accurate method to detect and characterize CP-GNB, including Enterobacteriaceae, P. aeruginosa, and A. baumannii complex; this approach provides additional diagnostic tools for prompt recognition of these pathogens and improves both clinical outcomes and infection prevention efforts (27 ) .
